Endomorphin-2 is a peptide amide with the highest known affinity and specificity for the mu-opioid receptor.
CAT No: R1853
CAS No: 141801-26-5
Synonyms/Alias: Endomorphin 2;Endomorphin-2;141801-26-5;tetrapeptide-15;Tyr-Pro-Phe-Phe-NH2;L-Phenylalaninamide, L-tyrosyl-L-prolyl-L-phenylalanyl-;H-Tyr-Pro-Phe-Phe-NH2;UNII-3PH5M0466G;3PH5M0466G;tyrosyl-prolyl-phenylalanyl-phenylalaninamide;CHEMBL333357;(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]-N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]pyrrolidine-2-carboxamide;DTXSID70415506;Endomorphin 2 TFA;(S)-1-(L-tyrosyl)-N-((S)-1-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)pyrrolidine-2-carboxamide;(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]formamido}-N-[(1S)-1-carbamoyl-2-phenylethyl]-3-phenylpropanamide;(S)-N-((S)-1-((S)-1-amino-1-oxo-3-phenylpropan-2-ylamino)-1-oxo-3-phenylpropan-2-yl)-1-((S)-2-amino-3-(4-hydroxyphenyl)propanoyl)pyrrolidine-2-carboxamide;(2S)-1-((2S)-2-amino-3-(4-hydroxyphenyl)propanoyl)-N-((2S)-1-(((2S)-1-amino-1-oxo-3-phenylpropan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)pyrrolidine-2-carboxamide;(2S)-2-((((2S)-1-((2S)-2-amino-3-(4-hydroxyphenyl)propanoyl)pyrrolidin-2-yl)(hydroxy)methylidene)amino)-N-((1S)-1-(C-hydroxycarbonimidoyl)-2-phenylethyl)-3-phenylpropanimidate;(2S)-2-(((2S)-1-((2S)-2-amino-3-(4-hydroxyphenyl)propanoyl)pyrrolidin-2-yl)formamido)-N-((1S)-1-carbamoyl-2-phenylethyl)-3-phenylpropanamide;(2S)-2-({[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-N-[(1S)-1-(C-hydroxycarbonimidoyl)-2-phenylethyl]-3-phenylpropanimidate;l-tyrosyl-l-prolyl-l-phenylalanyl-l-phenylalaninamide;GTPL3668;L-Phenylalaninamide,L-tyrosyl-L-prolyl-L-phenylalanyl-;TETRAPEPTIDE-15 [INCI];DTXCID60366356;XIJHWXXXIMEHKW-LJWNLINESA-N;C32H37N5O5;l-tyrosyl-l-prolyl-l-phenylalanyl-l-phenylalaninamide, (-)-;Endomorphin-2 trifluoroacetate salt;HY-P0186;BDBM50139013;HB2411;MFCD01321064;AKOS024456356;NCGC00163677-01;NCGC00163677-02;DA-73105;FE109150;H-Tyr-Pro-Phe-Phe-NH2; H-YPFF-NH2;TS-09634;G78410;Q19597070;(S)-1-[(S)-2-Amino-3-(4-hydroxy-phenyl)-propionyl]-pyrrolidine-2-carboxylic acid [(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-2-phenyl-ethyl]-amide;1-[(S)-2-Amino-3-(4-hydroxy-phenyl)-propionyl]-pyrrolidine-2-carboxylicacid[1-((S)-(S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-2-phenyl-ethyl]-amide;
Chemical Name: (2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]-N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]pyrrolidine-2-carboxamide
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C32H37N5O5 |
M.W/Mr. | 571.7 |
Sequence | One Letter Code:YPFF Three Letter Code:H-Tyr-Pro-Phe-Phe-NH2 |
Purity | > 95% |
Activity | Endogenous peptide with extremely high affinity and selectivity for μ-opioid receptors (with Ki values of 0.69, 9233 and 5240 nM for μ, δ and κ respectively). |
Long-term Storage Conditions | Soluble to 0.40 mg/ml in water |
Shipping Condition | Evaluation sample solution : ship with blue ice; All other available size: ship with RT , or blue ice upon request |
InChI | InChI=1S/C32H37N5O5/c33-25(18-23-13-15-24(38)16-14-23)32(42)37-17-7-12-28(37)31(41)36-27(20-22-10-5-2-6-11-22)30(40)35-26(29(34)39)19-21-8-3-1-4-9-21/h1-6,8-11,13-16,25-28,38H,7,12,17-20,33H2,(H2,34,39)(H,35,40)(H,36,41)/t25-,26-,27-,28-/m0/s1 |
InChI Key | XIJHWXXXIMEHKW-LJWNLINESA-N |
Canonical SMILES | C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CC=CC=C4)C(=O)N |
Isomeric SMILES | C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N |
2. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
5. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.